Search terms
Sleep and respiratory care
Search terms
| |
| |
| |
Average Volume Assured Pressure Support (AVAPS) therapy technology1 is designed to provide consistent tidal volume – e.g. volume of inhaled air – at the lowest minimum inspiratory pressure. AVAPS therapy maintains the low pressure required to achieve the prescribed tidal volume, with each and every breath. Patients can enjoy enhanced comfort and the confidence that the therapy is working effectively.
This article explores how hybrid mode AVAPS can be an effective therapy for chronic disease sufferers, whose disease progression and needs evolve.
Chronic obstructive pulmonary disease (COPD) is a common, often underdiagnosed, and debilitating disease. It is fourth leading cause of death worldwide and is estimated to be the third leading cause by 20202, and yet, there is still a lack of awareness and a social stigma associated with the disease.
Philips is committed to sustaining the education and moral support of patients, families and care givers impacted by COPD. Recently Philips joined forces with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to support World COPD Day.
This year, Philips joined forces with with Russell Winwood and his physician to help educate, engage and empower COPD patients and their caregivers. Russell Winwood, a COPD patient and advocate, shares his personal journey with other COPD patients to inspire them to live their lives to the fullest.
Philips InnoSpire Go is a virtually silent, handheld nebulizer designed as a fast, convenient, and portable treatment option for the rising population of both children and adults with chronic respiratory conditions. InnoSpire Go simplifies the delivery of inhaled medication, offering fast and effective four-minute treatment3, reducing treatment time by 25%4.
Available now:
COPD HOT HMV: Improving Admission-Free Survival in Persistent Hypercapnic COPD
New Editorial
1BiPAP AVAPS only
2Global Initiative for Chronic Obstructive Lung Disease. 2017. Retrieved from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd
3Using 2.5ml Salbutamol. Data on file.
4Versus predecessor, Aeroneb Go. Data on file.